期刊文献+

蕈样肉芽肿的免疫机制研究进展 被引量:1

下载PDF
导出
摘要 蕈样肉芽肿是原发于皮肤的T细胞淋巴瘤,系一种最常见的低度恶性皮肤非霍奇金淋巴瘤。免疫学异常与其发病密切相关,表现为患者皮损中树突状细胞分布和功能异常,T细胞凋亡增加,Fas表达下降和FasL表达增加,趋化因子及其受体、IL-4、IL-15、CTLA-4、HECA-452等免疫分子异常表达有关。MF免疫机制的阐明将为治疗MF提供更好的依据。
出处 《中国麻风皮肤病杂志》 2008年第1期43-45,共3页 China Journal of Leprosy and Skin Diseases
  • 相关文献

参考文献19

  • 1Odom RB, Janes WD, Berger TG. Andrews' Diseases of the Skin. 9th ed. Harcout Asia: WB Sauders, 2001.921 -929.
  • 2Linnemann T, Gellrich S, Lukowsky A, et al. Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T- cell lymphoma: evidence for possible superantigen involvement. Br J Dermatol 2004; 150:1013 - 1017.
  • 3冯爱平,Matthias Lüftl,Ecka Licha,Alexander Steinkasserer,刘志香,陈思远,连昕,涂亚庭.蕈样肉芽肿浸润性皮损中树突细胞表型特征的研究[J].中华皮肤科杂志,2003,36(10):565-567. 被引量:2
  • 4Luftl M, Feng A, Licha E, et al. Dendritic cells and apoptosis in mycosis fungoides. Br J Dermatol 2002;147:1171 - 1179.
  • 5Steinbrink KM, Wolff M, Jonuleit H, et al. Induction of tolerance by IL- 10-treated dendritic cell. J Immunol 1997;159:4772-4780.
  • 6Kikuki A, Nishikaws T. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Arch Dermatol 1997; 133:823 - 829.
  • 7Jenne L, Arrighi JF, Jonuleit H, et al. Dendritic cells containing apoptotic melanoma cells prime human CD^+ T cells for efficient tumor cell lysis. Cancer Res 2000;60:4446-4452.
  • 8Murakamim, Sasaki T, Miyata H, et al. Fas and Fas ligand: expression and soluble circulatinglevels in bile duct carcinoma. J Oncol Rep 2004;11:1183- 1186.
  • 9Verbeke CS, Wenthe U, Grobbolz R, et al. Fas ligand expression in Hodgkin lymphoma. J Am J Surg Pathol 2001 ;25:349 - 388.
  • 10O'Conell J, O'Sullivan GC, Ccllins JK, et al. The Fas counterattack: Fas- mediator T cell king by colon cancer cells express Fas lingand. J Exp Med 1996; 184:1054- 1082.

二级参考文献8

  • 1Lespagnard L, Gancberg D, Rouas G, et al. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer, 1999, 84:309-314.
  • 2Toriyama K, Wen DR, Paul E, et al. Variations in the distribution,frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J Invest Dermatol, 1993, 100:269S-273S.
  • 3Thurnher M, Radmayr C, Ramoner R, et al. Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer, 1996, 68:1-7.
  • 4Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med, 1999, 190:1417-1426.
  • 5Pimpinelli N, Santucci M, Romagnoli P, et al. Dendritic cells in Tand B-cell proliferation in the skin. Dermatol Clin, 1994, 12:255-270.
  • 6Fivenson DP, Nickoloff BJ. Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis. J Cutan Pathol, 1995, 22:223-228.
  • 7Willemze R, Kerl H, Sterry W, et al. EORTC classific ation for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood, 1997, 90:354-371.
  • 8Meissner K, Loning T, Rehpenning W. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome. In Vivo, 1993, 7:277-280.

共引文献1

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部